Tumor recurrence and malignant progression of gangliogliomas
Open Access
- 4 December 2008
- Vol. 113 (12), 3355-3363
- https://doi.org/10.1002/cncr.23965
Abstract
BACKGROUND. Most gangliogliomas (GGs) are benign tumors, but tumor recurrence and malignant progression are observed in some patients. METHODS. The authors analyzed their experience with 4 recurrent/progressive GGs (World Health Organization [WHO] grade I), 21 tumors with atypical features (WHO grade II), and 5 tumors with anaplastic histologic features (WHO grade III). Histopathologic findings (23 patients) were reviewed. The mean follow-up was 5.9 years (median, 4.5 years; range, 0.5-14.7 years). RESULTS. The 5-year survival rates were only 79% for patients who had tumors with atypical features and 53% for patients who had WHO grade III tumors. Secondary glioblastomas were diagnosed in 5 of 11 patients (45%) who underwent surgery for tumor recurrence. Age at surgery P = .007) was associated significantly with better overall survival (OS), but it was not associated with better progression-free survival (PFS). Clinical presentation (drug-resistant epilepsy vs all other patients with seizures vs no seizures) was associated significantly with better OS (P = .005) and PFS (P < .001). Patients who had extratemporal tumors had a significantly shorter PFS (P = .01) but not OS. A complete resection was correlated strongly with both OS (P = .002) and PFS (P = .001). Neuropathologic examination revealed the presence of a gemistocytic cell component (PFS, P = .025), a lack of protein droplets (OS, P = .04; PFS, P = .05), and focal tumor cell-associated CD34 immunolabeling (OS, P = .03) as significant predictors of an adverse clinical course. CONCLUSIONS. The current data supported a 3-tiered GG histopathologic grading system that included an intermediate diagnostic category (atypical GG, WHO grade II). Careful attention to histopathologic findings and clinical parameters usually will identify patients who are at risk for an adverse clinical course. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 30 references indexed in Scilit:
- THE SURGERY OF EPILEPSYNeurosurgery, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Malignant and benign ganglioglioma: A pathological and molecular study1Neuro-Oncology, 2007
- Repeated operations for infiltrative low-grade gliomas without intervening therapyJournal of Neurosurgery, 2003
- Ganglioglioma in a patient with Turcot syndromeJournal of Neurosurgery, 2000
- GangliogliomaCancer, 1997
- Neuropathologische Befunde bei chronischen EpilepsienLaryngo-Rhino-Otologie, 1995
- Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Central nervous system gangliogliomasJournal of Neurosurgery, 1993
- Temporal lobe tumor demonstrating ganglioglioma and pleomorphic xanthoastrocytoma componentsJournal of Neurosurgery, 1992